12/12/2012

Cytomedix has earned CE mark approval in Europe for use of its Angel concentrated platelet-rich plasma technology with bone marrow aspirate. The system, which was cleared by the FDA last month, includes adjustable settings to allow customized processing and preparation of plasma in clinical settings or at the point of care.

Related Summaries